Although some studies suggest that PCSK9 and APOA5 are positively associated with comorbid depression and obesity, reproducible associations with depressive symptoms are limited, given their strong metabolic effects [86,99,100]. Here, PCSK9 is linked to obesity due to melanocortin 4 receptor deficiency.